Clinical Trial Update: Radiotherapy Followed by Tiselizumab Combined With RCHOP in Previously Untreated Bulky Follicular Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing radiotherapy followed by Tiselizumab in combination with RCHOP for previously untreated bulky Follicular Lymphoma; recruitment …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Follicular Lymphoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Doxorubicin (doxorubicin)
• PREDNISONE (Prednisone)
• Rituximab (rituximab)
• Tiselizumab (Tiselizumab)
• Vincristine (vincristine)

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Follicular Lymphoma | Phase 2 | Status: RECRUITING